Tube and column agglutination technology for autocontrol testing

J. E. Courtney, J. L. Vincent, A. J. Indrikovs

Research output: Contribution to journalArticle

Abstract

The incidence of positive autocontrol test results with column agglutination technology is a concern. This study investigates the incidence and significance of positive autocontrols in the ID Micro Typing System™ (gel) and the Gamma ReACT™ (REACT). The study encompassed a total of 1021 randomly selected samples from patients and 95 samples from donors collected during 1 month. The autocontrol testing was carried out according to the manufacturer's instructions for the column agglutination tests. The tube method was carried out using low-ionic-strength solution (LISS). The direct antiglobulin test (DAT) was performed using the tube method, and further investigated with elution studies if warranted. Seventy-nine patient's samples (7.74%) had a positive autocontrol: the gel test, 72 (91.13%); ReACT, 21 (26.58%) and the tube method, 27 (34.18%). Of the 79 positive autocontrols, 44 samples had a negative DAT. Of the samples with positive DAT results, only one possessed a clinically significant antibody, anti-D. Moreover, the same sample also tested positive in all three methods. Column agglutination techniques have increased sensitivity for a positive autocontrol beyond the conventional tube method. However, ReACT and gel tests differ significantly in their frequency of positives. Investigation of the significance of a positive autocontrol in column agglutination technology when the conventional tube method is also positive is suggested.

Original languageEnglish (US)
Pages (from-to)50-52
Number of pages3
JournalImmunohematology
Volume17
Issue number2
StatePublished - 2001

Fingerprint

Agglutination
Technology
Coombs Test
Gels
Agglutination Tests
Osmolar Concentration
Cohort Studies
Tissue Donors
Antibodies
Incidence

Keywords

  • Autocontrol testing
  • ID Micro Typing System™
  • ReACT™

ASJC Scopus subject areas

  • Immunology
  • Hematology

Cite this

Courtney, J. E., Vincent, J. L., & Indrikovs, A. J. (2001). Tube and column agglutination technology for autocontrol testing. Immunohematology, 17(2), 50-52.

Tube and column agglutination technology for autocontrol testing. / Courtney, J. E.; Vincent, J. L.; Indrikovs, A. J.

In: Immunohematology, Vol. 17, No. 2, 2001, p. 50-52.

Research output: Contribution to journalArticle

Courtney, JE, Vincent, JL & Indrikovs, AJ 2001, 'Tube and column agglutination technology for autocontrol testing', Immunohematology, vol. 17, no. 2, pp. 50-52.
Courtney JE, Vincent JL, Indrikovs AJ. Tube and column agglutination technology for autocontrol testing. Immunohematology. 2001;17(2):50-52.
Courtney, J. E. ; Vincent, J. L. ; Indrikovs, A. J. / Tube and column agglutination technology for autocontrol testing. In: Immunohematology. 2001 ; Vol. 17, No. 2. pp. 50-52.
@article{12dfa70ea3604bcb848ab6a0ed55dd67,
title = "Tube and column agglutination technology for autocontrol testing",
abstract = "The incidence of positive autocontrol test results with column agglutination technology is a concern. This study investigates the incidence and significance of positive autocontrols in the ID Micro Typing System™ (gel) and the Gamma ReACT™ (REACT). The study encompassed a total of 1021 randomly selected samples from patients and 95 samples from donors collected during 1 month. The autocontrol testing was carried out according to the manufacturer's instructions for the column agglutination tests. The tube method was carried out using low-ionic-strength solution (LISS). The direct antiglobulin test (DAT) was performed using the tube method, and further investigated with elution studies if warranted. Seventy-nine patient's samples (7.74{\%}) had a positive autocontrol: the gel test, 72 (91.13{\%}); ReACT, 21 (26.58{\%}) and the tube method, 27 (34.18{\%}). Of the 79 positive autocontrols, 44 samples had a negative DAT. Of the samples with positive DAT results, only one possessed a clinically significant antibody, anti-D. Moreover, the same sample also tested positive in all three methods. Column agglutination techniques have increased sensitivity for a positive autocontrol beyond the conventional tube method. However, ReACT and gel tests differ significantly in their frequency of positives. Investigation of the significance of a positive autocontrol in column agglutination technology when the conventional tube method is also positive is suggested.",
keywords = "Autocontrol testing, ID Micro Typing System™, ReACT™",
author = "Courtney, {J. E.} and Vincent, {J. L.} and Indrikovs, {A. J.}",
year = "2001",
language = "English (US)",
volume = "17",
pages = "50--52",
journal = "Immunohematology",
issn = "0894-203X",
publisher = "American Red Cross",
number = "2",

}

TY - JOUR

T1 - Tube and column agglutination technology for autocontrol testing

AU - Courtney, J. E.

AU - Vincent, J. L.

AU - Indrikovs, A. J.

PY - 2001

Y1 - 2001

N2 - The incidence of positive autocontrol test results with column agglutination technology is a concern. This study investigates the incidence and significance of positive autocontrols in the ID Micro Typing System™ (gel) and the Gamma ReACT™ (REACT). The study encompassed a total of 1021 randomly selected samples from patients and 95 samples from donors collected during 1 month. The autocontrol testing was carried out according to the manufacturer's instructions for the column agglutination tests. The tube method was carried out using low-ionic-strength solution (LISS). The direct antiglobulin test (DAT) was performed using the tube method, and further investigated with elution studies if warranted. Seventy-nine patient's samples (7.74%) had a positive autocontrol: the gel test, 72 (91.13%); ReACT, 21 (26.58%) and the tube method, 27 (34.18%). Of the 79 positive autocontrols, 44 samples had a negative DAT. Of the samples with positive DAT results, only one possessed a clinically significant antibody, anti-D. Moreover, the same sample also tested positive in all three methods. Column agglutination techniques have increased sensitivity for a positive autocontrol beyond the conventional tube method. However, ReACT and gel tests differ significantly in their frequency of positives. Investigation of the significance of a positive autocontrol in column agglutination technology when the conventional tube method is also positive is suggested.

AB - The incidence of positive autocontrol test results with column agglutination technology is a concern. This study investigates the incidence and significance of positive autocontrols in the ID Micro Typing System™ (gel) and the Gamma ReACT™ (REACT). The study encompassed a total of 1021 randomly selected samples from patients and 95 samples from donors collected during 1 month. The autocontrol testing was carried out according to the manufacturer's instructions for the column agglutination tests. The tube method was carried out using low-ionic-strength solution (LISS). The direct antiglobulin test (DAT) was performed using the tube method, and further investigated with elution studies if warranted. Seventy-nine patient's samples (7.74%) had a positive autocontrol: the gel test, 72 (91.13%); ReACT, 21 (26.58%) and the tube method, 27 (34.18%). Of the 79 positive autocontrols, 44 samples had a negative DAT. Of the samples with positive DAT results, only one possessed a clinically significant antibody, anti-D. Moreover, the same sample also tested positive in all three methods. Column agglutination techniques have increased sensitivity for a positive autocontrol beyond the conventional tube method. However, ReACT and gel tests differ significantly in their frequency of positives. Investigation of the significance of a positive autocontrol in column agglutination technology when the conventional tube method is also positive is suggested.

KW - Autocontrol testing

KW - ID Micro Typing System™

KW - ReACT™

UR - http://www.scopus.com/inward/record.url?scp=0034972740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034972740&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 50

EP - 52

JO - Immunohematology

JF - Immunohematology

SN - 0894-203X

IS - 2

ER -